Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Protective immunity to systemic infection with attenuated Salmonella enterica serovar enteritidis in the absence of IL-12 is associated with IL-23-dependent IL-22, but not IL-17.

Schulz SM, Köhler G, Schütze N, Knauer J, Straubinger RK, Chackerian AA, Witte E, Wolk K, Sabat R, Iwakura Y, Holscher C, Müller U, Kastelein RA, Alber G.

J Immunol. 2008 Dec 1;181(11):7891-901.

2.

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.

Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA.

J Immunol. 2007 Aug 15;179(4):2551-5.

3.

Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection.

Chackerian AA, Chen SJ, Brodie SJ, Mattson JD, McClanahan TK, Kastelein RA, Bowman EP.

Infect Immun. 2006 Nov;74(11):6092-9. Epub 2006 Aug 21.

4.

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.

Bowman EP, Chackerian AA, Cua DJ.

Curr Opin Infect Dis. 2006 Jun;19(3):245-52. Review.

PMID:
16645485
5.

The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection.

Ghosh S, Chackerian AA, Parker CM, Ballantyne CM, Behar SM.

J Immunol. 2006 Apr 15;176(8):4914-22.

6.

Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice.

Chackerian AA, Behar SM.

Tuberculosis (Edinb). 2003;83(5):279-85. Review.

PMID:
12972341
7.

Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM.

Infect Immun. 2002 Aug;70(8):4501-9.

8.

Supplemental Content

Loading ...
Support Center